Jay S Skyler Dexcom Inc (DXCM) insider trading activity

DXCM Quotes by TradingView

Jay S Skyler is Director of DEXCOM INC. Currently has a direct ownership of 0 shares of DXCM, which is worth approximately $0. The most recent transaction as insider was on May 18, 2023, when has been sold 3,876 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

JAY S SKYLER Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2023
SELL
Bona fide gift
-
3,876 Reduced 100.0%
0 Common Stock
May 20 2022
BUY
Grant, award, or other acquisition
-
969 Added 50.0%
969 Common Stock
May 19 2022
SELL
Other acquisition or disposition
-
900 Reduced 100.0%
0 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
900 Added 50.0%
900 Common Stock
May 20 2021
SELL
Other acquisition or disposition
-
822 Reduced 100.0%
0 Common Stock

Also insider at

SABS
SAB Biotherapeutics, Inc. Healthcare
APLT
Applied Therapeutics Inc. Healthcare
JSS

Jay S Skyler

Director
New York, NY

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DXCM